摘要
本文通过查询近年文献,总结老年患者使用磺脲类药物(SUs)的风险主要表现为低血糖反应、心血管不良事件、致癌风险,为老年患者开具SUs时需综合评估患者病情,减少药物引起的不良事件发生。
Here we reviewed the risk of sulfonyluras therapy in eiderly population, including hypoglycemia, cardiovascular events and cancer risk by searching recent literatures. Comprehensive evaluation of patients' conditions should be done before prescribing sulfonylureas for the eldly patients, in order to reduce the occurrence of adverse drug events caused by sulfonylureas.
出处
《中国糖尿病杂志》
CAS
CSCD
北大核心
2017年第5期477-480,共4页
Chinese Journal of Diabetes
关键词
磺脲类药物
低血糖
大血管事件
致癌风险
Sulfonylureas (SUs)
H ypogl ycemia
Macrovas cular events
Cancer risk